Bệnh sinh học của Đái tháo đường loại 2

Roden, 2019, The integrative biology of type 2 diabetes, Nature, 576, 51, 10.1038/s41586-019-1797-8

Stumvoll, 2005, Type 2 diabetes: Principles of pathogenesis and therapy, Lancet, 365, 1333, 10.1016/S0140-6736(05)61032-X

Weyer, 1999, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus, J. Clin. Investig., 104, 787, 10.1172/JCI7231

Chatterjee, 2017, Type 2 diabetes, Lancet, 389, 2239, 10.1016/S0140-6736(17)30058-2

NCD Risk Factor Collaboration (2016). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet, 387, 1513–1530.

Defronzo, 2009, From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus, Diabetes, 58, 773, 10.2337/db09-9028

Schwartz, 2016, The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the beta-Cell-Centric Classification Schema, Diabetes Care, 39, 179, 10.2337/dc15-1585

Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N. Engl. J. Med., 348, 383, 10.1056/NEJMoa021778

Sarwar, 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9

Grarup, 2014, Genetic susceptibility to type 2 diabetes and obesity: From genome-wide association studies to rare variants and beyond, Diabetologia, 57, 1528, 10.1007/s00125-014-3270-4

Wong, 2016, Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study, Diabetes Care, 39, 668, 10.2337/dc15-2439

Hu, 2001, Diet, lifestyle, and the risk of type 2 diabetes mellitus in women, N. Engl. J. Med., 345, 790, 10.1056/NEJMoa010492

Schellenberg, 2013, Lifestyle interventions for patients with and at risk for type 2 diabetes: A systematic review and meta-analysis, Ann. Intern. Med., 159, 543, 10.7326/0003-4819-159-8-201310150-00007

Chan, 1993, Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM), Postgrad. Med. J., 69, 204, 10.1136/pgmj.69.809.204

Dabelea, 2009, Search for Diabetes in Navajo youth: Prevalence, incidence, and clinical characteristics: The Search for Diabetes in Youth Study, Diabetes Care, 32, S141, 10.2337/dc09-S206

Liu, 2009, Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: The SEARCH for Diabetes in Youth Study, Diabetes Care, 32, S133, 10.2337/dc09-S205

Karter, 2013, Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE), Diabetes Care, 36, 574, 10.2337/dc12-0722

Sattar, 2015, Type 2 diabetes in migrant south Asians: Mechanisms, mitigation, and management, Lancet Diabetes Endocrinol., 3, 1004, 10.1016/S2213-8587(15)00326-5

McKeigue, 1991, Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians, Lancet, 337, 382, 10.1016/0140-6736(91)91164-P

Haines, 2007, Rising incidence of type 2 diabetes in children in the U.K, Diabetes Care, 30, 1097, 10.2337/dc06-1813

Fuchsberger, 2016, The genetic architecture of type 2 diabetes, Nature, 536, 41, 10.1038/nature18642

McCarthy, 2010, Genomics, type 2 diabetes, and obesity, N. Engl. J. Med., 363, 2339, 10.1056/NEJMra0906948

Dimas, 2014, Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity, Diabetes, 63, 2158, 10.2337/db13-0949

Flannick, 2016, Type 2 diabetes: Genetic data sharing to advance complex disease research, Nat. Rev. Genet., 17, 535, 10.1038/nrg.2016.56

Franks, 2013, Gene-environment and gene-treatment interactions in type 2 diabetes: Progress, pitfalls, and prospects, Diabetes Care, 36, 1413, 10.2337/dc12-2211

Bellou, V., Belbasis, L., Tzoulaki, I., and Evangelou, E. (2018). Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS ONE, 13.

Carey, 1997, Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study, Am. J. Epidemiol., 145, 614, 10.1093/oxfordjournals.aje.a009158

Sinha, 2002, Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: Relationships to insulin sensitivity, total body fat, and central adiposity, Diabetes, 51, 1022, 10.2337/diabetes.51.4.1022

Hillier, 2003, Complications in young adults with early-onset type 2 diabetes: Losing the relative protection of youth, Diabetes Care, 26, 2999, 10.2337/diacare.26.11.2999

Weinstein, 2004, Relationship of physical activity vs body mass index with type 2 diabetes in women, JAMA, 292, 1188, 10.1001/jama.292.10.1188

Lynch, 1996, Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men, Arch. Intern. Med., 156, 1307, 10.1001/archinte.1996.00440110073010

Venkatasamy, 2013, Effect of Physical activity on Insulin Resistance, Inflammation and Oxidative Stress in Diabetes Mellitus, J. Clin. Diagn. Res., 7, 1764

Strasser, 2013, Physical activity in obesity and metabolic syndrome, Ann. N. Y. Acad. Sci., 1281, 141, 10.1111/j.1749-6632.2012.06785.x

Ross, 2003, Does exercise without weight loss improve insulin sensitivity?, Diabetes Care, 26, 944, 10.2337/diacare.26.3.944

Cerf, 2013, Beta cell dysfunction and insulin resistance, Front. Endocrinol. (Lausanne), 4, 37, 10.3389/fendo.2013.00037

Zheng, 2018, Global aetiology and epidemiology of type 2 diabetes mellitus and its complications, Nat. Rev. Endocrinol., 14, 88, 10.1038/nrendo.2017.151

Bunney, 2017, Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet, Physiol. Behav., 176, 139, 10.1016/j.physbeh.2017.03.040

Fu, 2013, Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes, Curr. Diabetes Rev., 9, 25, 10.2174/157339913804143225

Halban, 1994, Proinsulin processing in the regulated and the constitutive secretory pathway, Diabetologia, 37, S65, 10.1007/BF00400828

Boland, 2017, The dynamic plasticity of insulin production in beta-cells, Mol. Metab., 6, 958, 10.1016/j.molmet.2017.04.010

Rorsman, 2018, Pancreatic beta-Cell Electrical Activity and Insulin Secretion: Of Mice and Men, Physiol. Rev., 98, 117, 10.1152/physrev.00008.2017

Seino, 2011, Dynamics of insulin secretion and the clinical implications for obesity and diabetes, J. Clin. Investig., 121, 2118, 10.1172/JCI45680

Islam, 2002, The ryanodine receptor calcium channel of beta-cells: Molecular regulation and physiological significance, Diabetes, 51, 1299, 10.2337/diabetes.51.5.1299

Cuinas, 2016, Activation of PKA and Epac proteins by cyclic AMP depletes intracellular calcium stores and reduces calcium availability for vasoconstriction, Life Sci., 155, 102, 10.1016/j.lfs.2016.03.059

Lustig, 1993, Expression cloning of an ATP receptor from mouse neuroblastoma cells, Proc. Natl. Acad. Sci. USA, 90, 5113, 10.1073/pnas.90.11.5113

Simon, 1995, Characterisation of a recombinant P2Y purinoceptor, Eur. J. Pharmacol., 291, 281, 10.1016/0922-4106(95)90068-3

Valera, 1994, A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP, Nature, 371, 516, 10.1038/371516a0

Blachier, 1988, Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells, Biochim. Biophys. Acta, 970, 222, 10.1016/0167-4889(88)90182-6

Li, 1991, Extracellular ATP causes Ca2(+)− dependent and -independent insulin secretion in RINm5F cells. Phospholipase C mediates Ca2+ mobilization but not Ca2+ influx and membrane depolarization, J. Biol. Chem., 266, 3449, 10.1016/S0021-9258(19)67816-6

Christensen, 2019, The Beta Cell in Type 2 Diabetes, Curr. Diabetes Rep., 19, 81, 10.1007/s11892-019-1196-4

Halban, 2014, beta-cell failure in type 2 diabetes: Postulated mechanisms and prospects for prevention and treatment, Diabetes Care, 37, 1751, 10.2337/dc14-0396

Yamamoto, 2019, Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic beta cell, J. Biol. Chem., 294, 168, 10.1074/jbc.RA118.005683

Thorn, 2015, Insulin secretion from beta cells within intact islets: Location matters, Clin. Exp. Pharmacol. Physiol., 42, 406, 10.1111/1440-1681.12368

Liu, 2018, Biosynthesis, structure, and folding of the insulin precursor protein, Diabetes Obes. Metab., 20, 28, 10.1111/dom.13378

Mecili, 2013, Metabolic inflammation: Connecting obesity and insulin resistance, Ann. Med., 45, 242, 10.3109/07853890.2012.705015

Hummasti, 2010, Endoplasmic reticulum stress and inflammation in obesity and diabetes, Circ. Res., 107, 579, 10.1161/CIRCRESAHA.110.225698

Roca-Rivada, A., Castelao, C., Senin, L.L., Landrove, M.O., Baltar, J., Belen Crujeiras, A., Seoane, L.M., Casanueva, F.F., and Pardo, M. (2013). FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE, 8.

Giacco, 2010, Oxidative stress and diabetic complications, Circ. Res., 107, 1058, 10.1161/CIRCRESAHA.110.223545

Graciano, 2011, Regulation of insulin secretion and reactive oxygen species production by free fatty acids in pancreatic islets, Islets, 3, 213, 10.4161/isl.3.5.15935

Esser, 2014, Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes, Diabetes Res. Clin. Pract., 105, 141, 10.1016/j.diabres.2014.04.006

Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327

Vandanmagsar, 2011, The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, Nat. Med., 17, 179, 10.1038/nm.2279

Association, 2019, Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019, Diabetes Care, 42, S29, 10.2337/dc19-S003

Shamsuzzaman, 2004, Independent association between plasma leptin and C-reactive protein in healthy humans, Circulation, 109, 2181, 10.1161/01.CIR.0000127960.28627.75

Leeuwenburgh, 1994, Aging and exercise training in skeletal muscle: Responses of glutathione and antioxidant enzyme systems, Am. J. Physiol., 267, R439

Polak, 2017, New markers of insulin resistance in polycystic ovary syndrome, J. Endocrinol. Investig., 40, 1, 10.1007/s40618-016-0523-8

Bostrom, 2012, A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, Nature, 481, 463, 10.1038/nature10777

Handschin, 2008, The role of exercise and PGC1alpha in inflammation and chronic disease, Nature, 454, 463, 10.1038/nature07206

Park, 2013, Circulating irisin in relation to insulin resistance and the metabolic syndrome, J. Clin. Endocrinol. Metab., 98, 4899, 10.1210/jc.2013-2373

Ibrahim, 2018, Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus, Diabetes Metab. Syndr., 12, 643, 10.1016/j.dsx.2018.04.025

Lynch, 2016, The Human Intestinal Microbiome in Health and Disease, N. Engl. J. Med., 375, 2369, 10.1056/NEJMra1600266

Kasper, 2014, Gut microbiome and the risk factors in central nervous system autoimmunity, FEBS Lett., 588, 4214, 10.1016/j.febslet.2014.09.024

Scarpellini, 2012, Obesity and metabolic syndrome: An inflammatory condition, Dig. Dis., 30, 148, 10.1159/000336664

Biagi, 2012, Aging of the human metaorganism: The microbial counterpart, Age (Dordrecht), 34, 247, 10.1007/s11357-011-9217-5

Sircana, 2018, Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?, Curr. Diabetes Rep., 18, 98, 10.1007/s11892-018-1057-6

Li, 2017, Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases, Front. Immunol., 8, 1882, 10.3389/fimmu.2017.01882

Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491

Tan, 2014, The role of short-chain fatty acids in health and disease, Adv. Immunol., 121, 91, 10.1016/B978-0-12-800100-4.00003-9

Tang, 2015, Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes, Nat. Med., 21, 173, 10.1038/nm.3779

Neis, 2015, The role of microbial amino acid metabolism in host metabolism, Nutrients, 7, 2930, 10.3390/nu7042930

Shan, 2017, Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes, Am. J. Clin. Nutr., 106, 888, 10.3945/ajcn.117.157107

Turner, 1999, Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group, JAMA, 281, 2005, 10.1001/jama.281.21.2005

Gaede, 2003, The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes, Ugeskr. Laeger., 165, 2658

Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N. Engl. J. Med., 359, 1577, 10.1056/NEJMoa0806470

Ihnat, 2007, Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling, Diabetologia, 50, 1523, 10.1007/s00125-007-0684-2

Ceriello, 2009, Clinical review 2: The “metabolic memory”: Is more than just tight glucose control necessary to prevent diabetic complications?, J. Clin. Endocrinol. Metab., 94, 410, 10.1210/jc.2008-1824

Engerman, 1989, Pathogenesis of diabetic retinopathy, Diabetes, 38, 1203, 10.2337/diab.38.10.1203

Olsen, 2012, Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression, Diabetes, 61, 485, 10.2337/db11-0588

Simmons, 2008, Epigenetic Influences and Disease, Nat. Educ., 1, 6

Rosen, 2018, Epigenetics and Epigenomics: Implications for Diabetes and Obesity, Diabetes, 67, 1923, 10.2337/db18-0537

Wahid, 2010, MicroRNAs: Synthesis, mechanism, function, and recent clinical trials, Biochim. Biophys. Acta, 1803, 1231, 10.1016/j.bbamcr.2010.06.013

LaPierre, 2017, MicroRNAs as stress regulators in pancreatic beta cells and diabetes, Mol. Metab., 6, 1010, 10.1016/j.molmet.2017.06.020

Esguerra, 2018, MicroRNAs in islet hormone secretion, Diabetes Obes. Metab., 20, 11, 10.1111/dom.13382

Ofori, 2017, Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell, Sci. Rep., 7, 44986, 10.1038/srep44986

Latreille, 2014, MicroRNA-7a regulates pancreatic beta cell function, J. Clin. Investig., 124, 2722, 10.1172/JCI73066

Poy, 2009, miR-375 maintains normal pancreatic alpha- and beta-cell mass, Proc. Natl. Acad. Sci. USA, 106, 5813, 10.1073/pnas.0810550106

Latreille, 2015, miR-375 gene dosage in pancreatic beta-cells: Implications for regulation of beta-cell mass and biomarker development, J. Mol. Med. (Berl.), 93, 1159, 10.1007/s00109-015-1296-9

Reddy, 2015, Epigenetic mechanisms in diabetic complications and metabolic memory, Diabetologia, 58, 443, 10.1007/s00125-014-3462-y

Blomen, 2011, Stable transmission of reversible modifications: Maintenance of epigenetic information through the cell cycle, Cell. Mol. Life Sci., 68, 27, 10.1007/s00018-010-0505-5

Bogdanovic, 2009, DNA methylation and methyl-CpG binding proteins: Developmental requirements and function, Chromosoma, 118, 549, 10.1007/s00412-009-0221-9

Mosammaparast, 2010, Reversal of histone methylation: Biochemical and molecular mechanisms of histone demethylases, Annu. Rev. Biochem., 79, 155, 10.1146/annurev.biochem.78.070907.103946

Breving, 2010, The complexities of microRNA regulation: Mirandering around the rules, Int. J. Biochem. Cell. Biol., 42, 1316, 10.1016/j.biocel.2009.09.016

Brasacchio, 2009, Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail, Diabetes, 58, 1229, 10.2337/db08-1666

Miao, 2004, In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions, J. Biol. Chem., 279, 18091, 10.1074/jbc.M311786200

Reddy, 2011, Epigenetic mechanisms in diabetic vascular complications, Cardiovasc. Res., 90, 421, 10.1093/cvr/cvr024

Karnib, 2016, Epigenetic changes in diabetes, Neurosci. Lett., 625, 64, 10.1016/j.neulet.2016.04.046

Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121

Kowluru, 2007, Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries, Exp. Diabetes Res., 2007, 21976, 10.1155/2007/21976

Kowluru, 2004, Reversal of hyperglycemia and diabetic nephropathy: Effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats, J. Diabetes Complicat., 18, 282, 10.1016/j.jdiacomp.2004.03.002

Thompson, 2013, Potential role of Toll-like receptors in programming of vascular dysfunction, Clin. Sci. (Lond.), 125, 19, 10.1042/CS20120673

Guarner, 2015, Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease, Interdiscip. Top Gerontol., 40, 99

Kim, 2008, Role of mitochondrial dysfunction in insulin resistance, Circ. Res., 102, 401, 10.1161/CIRCRESAHA.107.165472

Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts, Proc. Natl. Acad. Sci. USA, 100, 7996, 10.1073/pnas.1332551100

Petersen, 2003, Mitochondrial dysfunction in the elderly: Possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Sazanov, 2015, A giant molecular proton pump: Structure and mechanism of respiratory complex I, Nat. Rev. Mol. Cell. Biol., 16, 375, 10.1038/nrm3997

Anonymous (2018). Focusing on mitochondrial form and function. Nat. Cell. Biol., 20, 735.

Spinelli, 2018, The multifaceted contributions of mitochondria to cellular metabolism, Nat. Cell. Biol., 20, 745, 10.1038/s41556-018-0124-1

Shigenaga, 1994, Oxidative damage and mitochondrial decay in aging, Proc. Natl. Acad. Sci. USA, 91, 10771, 10.1073/pnas.91.23.10771

Sergi, 2019, Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet, Front. Physiol., 10, 532, 10.3389/fphys.2019.00532

Kelley, 1999, Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss, Am. J. Physiol., 277, E1130

Simoneau, 1999, Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss, FASEB J., 13, 2051, 10.1096/fasebj.13.14.2051

Kim, 2000, Lipid oxidation is reduced in obese human skeletal muscle, Am. J. Physiol. Endocrinol. Metab., 279, E1039, 10.1152/ajpendo.2000.279.5.E1039

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180

Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466, 10.1073/pnas.1032913100

Kooi, 2007, Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects, Diabetologia, 50, 113, 10.1007/s00125-006-0475-1

Phielix, 2008, Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients, Diabetes, 57, 2943, 10.2337/db08-0391

Schieber, 2014, ROS function in redox signaling and oxidative stress, Curr. Biol., 24, R453, 10.1016/j.cub.2014.03.034

Ezraty, 2017, Oxidative stress, protein damage and repair in bacteria, Nat. Rev. Microbiol., 15, 385, 10.1038/nrmicro.2017.26

Ceriello, 2012, The emerging challenge in diabetes: The “metabolic memory”, Vascul. Pharmacol., 57, 133, 10.1016/j.vph.2012.05.005

Johnson, 2012, The inflammation highway: Metabolism accelerates inflammatory traffic in obesity, Immunol. Rev., 249, 218, 10.1111/j.1600-065X.2012.01151.x

Schofield, J.H., and Schafer, Z.T. (2020). Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship. Antioxid. Redox. Signal.

Montgomery, 2015, Mitochondrial dysfunction and insulin resistance: An update, Endocr. Connect., 4, R1, 10.1530/EC-14-0092

Chavez, 2012, A ceramide-centric view of insulin resistance, Cell. Metab., 15, 585, 10.1016/j.cmet.2012.04.002

Liang, 2006, PGC-1alpha: A key regulator of energy metabolism, Adv. Physiol. Educ., 30, 145, 10.1152/advan.00052.2006

Bach, 2005, Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: Effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6, Diabetes, 54, 2685, 10.2337/diabetes.54.9.2685

Novak, 2012, Mitophagy: A complex mechanism of mitochondrial removal, Antioxid. Redox. Signal, 17, 794, 10.1089/ars.2011.4407

Wei, 2015, Selective removal of mitochondria via mitophagy: Distinct pathways for different mitochondrial stresses, Biochim. Biophys. Acta, 1853, 2784, 10.1016/j.bbamcr.2015.03.013

Ding, 2012, Mitophagy: Mechanisms, pathophysiological roles, and analysis, Biol. Chem., 393, 547, 10.1515/hsz-2012-0119

Westermann, 2010, Mitochondrial fusion and fission in cell life and death, Nat. Rev. Mol. Cell. Biol., 11, 872, 10.1038/nrm3013

Yang, 2010, Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance, Cell. Metab., 11, 467, 10.1016/j.cmet.2010.04.005

Quiros, 2012, Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice, EMBO J., 31, 2117, 10.1038/emboj.2012.70

Sebastian, 2012, Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis, Proc. Natl. Acad. Sci. USA, 109, 5523, 10.1073/pnas.1108220109

Jheng, 2012, Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle, Mol. Cell. Biol., 32, 309, 10.1128/MCB.05603-11

Lin, 2018, The Causal Role of Mitochondrial Dynamics in Regulating Insulin Resistance in Diabetes: Link through Mitochondrial Reactive Oxygen Species, Oxid. Med. Cell. Longev., 2018, 7514383, 10.1155/2018/7514383

Lionetti, L., Mollica, M.P., Donizzetti, I., Gifuni, G., Sica, R., Pignalosa, A., Cavaliere, G., Gaita, M., De Filippo, C., and Zorzano, A. (2014). High-lard and high-fish-oil diets differ in their effects on function and dynamic behaviour of rat hepatic mitochondria. PLoS ONE, 9.

Kadowaki, 1994, A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA, N. Engl. J. Med., 330, 962, 10.1056/NEJM199404073301403

Yang, 2012, Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes, Mol. Endocrinol., 26, 1203, 10.1210/me.2012-1004

Tawata, 2000, A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes, Diabetes, 49, 1269, 10.2337/diabetes.49.7.1269

Wang, 2001, Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients, Exp. Clin. Endocrinol. Diabetes, 109, 361, 10.1055/s-2001-17407

Tawata, 1998, New mitochondrial DNA homoplasmic mutations associated with Japanese patients with type 2 diabetes, Diabetes, 47, 276, 10.2337/diab.47.2.276

Poulton, 2002, Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study, Hum. Mol. Genet., 11, 1581, 10.1093/hmg/11.13.1581

Tang, 2006, Variation of mitochondrial gene and the association with type 2 diabetes mellitus in a Chinese population, Diabetes Res. Clin. Pract., 73, 77, 10.1016/j.diabres.2005.12.001

Czech, 2017, Insulin action and resistance in obesity and type 2 diabetes, Nat. Med., 23, 804, 10.1038/nm.4350

Pearson, 2016, The Effects of Insulin Resistance on Individual Tissues: An Application of a Mathematical Model of Metabolism in Humans, Bull. Math. Biol., 78, 1189, 10.1007/s11538-016-0181-1

Wilcox, 2005, Insulin and insulin resistance, Clin. Biochem. Rev., 26, 19

Nussey, S., and Whitehead, S. (2001). Endocrinology: An Integrated Approach, BIOS Scientific Publishers.

Petersen, 2002, Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus, Am. J. Cardiol., 90, 11G, 10.1016/S0002-9149(02)02554-7

Petersen, 2002, Cellular mechanism of insulin resistance in skeletal muscle, J. R Soc. Med., 95, 8

Satoh, 2014, Molecular mechanisms for the regulation of insulin-stimulated glucose uptake by small guanosine triphosphatases in skeletal muscle and adipocytes, Int. J. Mol. Sci., 15, 18677, 10.3390/ijms151018677

DeFronzo, 1988, Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM, Diabetes, 37, 667, 10.2337/diab.37.6.667

DeFronzo, 2010, Pathogenesis of insulin resistance in skeletal muscle, J. Biomed. Biotechnol., 2010, 476279

Wu, 2017, Skeletal muscle inflammation and insulin resistance in obesity, J. Clin. Investig., 127, 43, 10.1172/JCI88880

Coelho, 2013, Biochemistry of adipose tissue: An endocrine organ, Arch. Med. Sci., 9, 191, 10.5114/aoms.2013.33181

Rosen, 2006, Adipocytes as regulators of energy balance and glucose homeostasis, Nature, 444, 847, 10.1038/nature05483

Gastaldelli, 2017, Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study, Diabetes, 66, 815, 10.2337/db16-1167

Czech, 2020, Mechanisms of insulin resistance related to white, beige, and brown adipocytes, Mol. Metab., 34, 27, 10.1016/j.molmet.2019.12.014

Scherer, 2019, The many secret lives of adipocytes: Implications for diabetes, Diabetologia, 62, 223, 10.1007/s00125-018-4777-x

Maki, 2011, Validation of insulin sensitivity and secretion indices derived from the liquid meal tolerance test, Diabetes Technol. Ther., 13, 661, 10.1089/dia.2010.0240

Titchenell, 2017, Unraveling the Regulation of Hepatic Metabolism by Insulin, Trends Endocrinol. Metab., 28, 497, 10.1016/j.tem.2017.03.003

Cherrington, 2007, Insulin action on the liver in vivo, Biochem. Soc. Trans., 35, 1171, 10.1042/BST0351171

Edgerton, 2006, Insulin’s direct effects on the liver dominate the control of hepatic glucose production, J. Clin. Investig., 116, 521, 10.1172/JCI27073

Gerin, 2002, The glucose-6-phosphatase system, Biochem. J., 362, 513, 10.1042/bj3620513

Oh, 2013, CREB and FoxO1: Two transcription factors for the regulation of hepatic gluconeogenesis, BMB Rep., 46, 567, 10.5483/BMBRep.2013.46.12.248

Montal, 2015, PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth, Mol. Cell., 60, 571, 10.1016/j.molcel.2015.09.025

Leclercq, 2007, Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences, J. Hepatol., 47, 142, 10.1016/j.jhep.2007.04.002

Meshkani, 2009, Hepatic insulin resistance, metabolic syndrome and cardiovascular disease, Clin. Biochem., 42, 1331, 10.1016/j.clinbiochem.2009.05.018

Gast, K.B., Tjeerdema, N., Stijnen, T., Smit, J.W., and Dekkers, O.M. (2012). Insulin resistance and risk of incident cardiovascular events in adults without diabetes: Meta-analysis. PLoS ONE, 7.

Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N. Engl. J. Med., 339, 229, 10.1056/NEJM199807233390404

Beckman, 2002, Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570

Nesto, 2004, Correlation between cardiovascular disease and diabetes mellitus: Current concepts, Am. J. Med., 116, 11S, 10.1016/j.amjmed.2003.10.016

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143–3421.

Reaven, 2012, Insulin resistance and coronary heart disease in nondiabetic individuals, Arterioscler. Thromb. Vasc. Biol., 32, 1754, 10.1161/ATVBAHA.111.241885

Bornfeldt, 2011, Insulin resistance, hyperglycemia, and atherosclerosis, Cell. Metab., 14, 575, 10.1016/j.cmet.2011.07.015

Davidson, 2009, Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes, Diabetes Care, 32, S331, 10.2337/dc09-S333

Laakso, 2014, Insulin resistance and hyperglycaemia in cardiovascular disease development, Nat. Rev. Endocrinol., 10, 293, 10.1038/nrendo.2014.29

Battisti, 2003, Dyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease, Clin. Chem. Lab. Med., 41, 1174, 10.1515/CCLM.2003.181

Lewis, 1996, Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state, Diabetes Care, 19, 390, 10.2337/diacare.19.4.390

Sparks, 2012, Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia, Arterioscler. Thromb. Vasc. Biol., 32, 2104, 10.1161/ATVBAHA.111.241463

Verges, 2015, Pathophysiology of diabetic dyslipidaemia: Where are we?, Diabetologia, 58, 886, 10.1007/s00125-015-3525-8

Taskinen, 2003, Diabetic dyslipidaemia: From basic research to clinical practice, Diabetologia, 46, 733, 10.1007/s00125-003-1111-y

Chapman, 2011, Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management, Eur. Heart J., 32, 1345, 10.1093/eurheartj/ehr112

Nordestgaard, 2014, Triglycerides and cardiovascular disease, Lancet, 384, 626, 10.1016/S0140-6736(14)61177-6

Boren, 2014, Postprandial hypertriglyceridemia as a coronary risk factor, Clin. Chim. Acta, 431, 131, 10.1016/j.cca.2014.01.015

Kroon, 2016, Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?, Curr. Cardiol. Rep., 18, 67, 10.1007/s11886-016-0745-6

Varbo, 2018, Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study, Clin. Chem., 64, 219, 10.1373/clinchem.2017.279463

Verweij, 2017, Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans, Arterioscler. Thromb. Vasc. Biol., 37, 969, 10.1161/ATVBAHA.116.308834

Steinberg, 1989, Lipoproteins and the pathogenesis of atherosclerosis, Circulation, 80, 719, 10.1161/01.CIR.80.3.719

Cohn, 1999, Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins, Arterioscler. Thromb. Vasc. Biol., 19, 2474, 10.1161/01.ATV.19.10.2474

Grundy, 2006, Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement, Curr. Opin. Cardiol., 21, 1, 10.1097/01.hco.0000200416.65370.a0

Grundy, 2006, Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds, J. Am. Coll. Cardiol., 47, 1093, 10.1016/j.jacc.2005.11.046

Ginsberg, 1991, Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis, Diabetes Care, 14, 839, 10.2337/diacare.14.9.839

Adiels, 2005, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia, Arterioscler. Thromb. Vasc. Biol., 25, 1697, 10.1161/01.ATV.0000172689.53992.25

Verges, 2010, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes, Atherosclerosis, 211, 353, 10.1016/j.atherosclerosis.2010.01.028

Lin, 1995, Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: Insulin negatively regulates MTP gene expression, J. Lipid. Res., 36, 1073, 10.1016/S0022-2275(20)39865-5

Blasiole, 2007, The physiological and molecular regulation of lipoprotein assembly and secretion, Mol. Biosyst., 3, 608, 10.1039/b700706j

Fisher, 2002, Complexity in the secretory pathway: The assembly and secretion of apolipoprotein B-containing lipoproteins, J. Biol. Chem., 277, 17377, 10.1074/jbc.R100068200

Choi, 2011, Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance, Trends Endocrinol. Metab., 22, 353, 10.1016/j.tem.2011.04.007

Horton, 2002, SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Investig., 109, 1125, 10.1172/JCI0215593

Kanter, 2019, Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes, J. Clin. Investig., 129, 4165, 10.1172/JCI127308

Haas, 2013, The regulation of ApoB metabolism by insulin, Trends Endocrinol. Metab., 24, 391, 10.1016/j.tem.2013.04.001

Laatsch, 2009, Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance, Atherosclerosis, 204, 105, 10.1016/j.atherosclerosis.2008.07.046

Gordts, 2016, ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors, J. Clin. Investig., 126, 2855, 10.1172/JCI86610

Toth, 2013, High-density lipoproteins: A consensus statement from the National Lipid Association, J. Clin. Lipidol., 7, 484, 10.1016/j.jacl.2013.08.001

Lewis, 2005, New insights into the regulation of HDL metabolism and reverse cholesterol transport, Circ. Res., 96, 1221, 10.1161/01.RES.0000170946.56981.5c

Fogelman, 1985, Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages, J. Biol. Chem., 260, 8783, 10.1016/S0021-9258(17)39420-6

Krauss, 2004, Lipids and lipoproteins in patients with type 2 diabetes, Diabetes Care, 27, 1496, 10.2337/diacare.27.6.1496

Lamarche, 1999, Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men, J. Clin. Investig., 103, 1191, 10.1172/JCI5286

Navab, 2011, HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms, Nat. Rev. Cardiol., 8, 222, 10.1038/nrcardio.2010.222

Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N. Engl. J. Med., 364, 127, 10.1056/NEJMoa1001689

Zhou, 2009, Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus, Diabetes Vasc. Dis. Res., 6, 238, 10.1177/1479164109344934

Lathief, 2016, Approach to diabetes management in patients with CVD, Trends Cardiovasc. Med., 26, 165, 10.1016/j.tcm.2015.05.005

Ference, 2017, Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel, Eur. Heart J., 38, 2459, 10.1093/eurheartj/ehx144

McNamara, 1996, Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B, J. Lipid. Res., 37, 1924, 10.1016/S0022-2275(20)37557-X

Chait, 1993, Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B, Am. J. Med., 94, 350, 10.1016/0002-9343(93)90144-E

Hoogeveen, 2014, Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study, Arterioscler. Thromb. Vasc. Biol., 34, 1069, 10.1161/ATVBAHA.114.303284

Witztum, 1982, Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity, Diabetes, 31, 283, 10.2337/diab.31.4.283

Bays, 2013, Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association, J. Clin. Lipidol., 7, 304, 10.1016/j.jacl.2013.04.001

Mooradian, 2004, Transcriptional control of apolipoprotein A-I gene expression in diabetes, Diabetes, 53, 513, 10.2337/diabetes.53.3.513

Chung, 2011, Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo, Circulation, 124, 1663, 10.1161/CIRCULATIONAHA.111.025445

McGillicuddy, 2011, Adipose modulation of high-density lipoprotein cholesterol: Implications for obesity, high-density lipoprotein metabolism, and cardiovascular disease, Circulation, 124, 1602, 10.1161/CIRCULATIONAHA.111.058453

Zhang, 2010, Adipocyte modulation of high-density lipoprotein cholesterol, Circulation, 121, 1347, 10.1161/CIRCULATIONAHA.109.897330

Farbstein, 2012, HDL dysfunction in diabetes: Causes and possible treatments, Expert Rev. Cardiovasc. Ther., 10, 353, 10.1586/erc.11.182

Eckel, 2005, The metabolic syndrome, Lancet, 365, 1415, 10.1016/S0140-6736(05)66378-7

Ginsberg, 2000, Insulin resistance and cardiovascular disease, J. Clin. Investig., 106, 453, 10.1172/JCI10762

Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9

Guyton, 2013, Relationship of lipoproteins to cardiovascular events: The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes), J. Am. Coll. Cardiol., 62, 1580, 10.1016/j.jacc.2013.07.023

Athyros, 2011, Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: The case for residual risk reduction after statin treatment, Open Cardiovasc. Med. J., 5, 24, 10.2174/1874192401105010024

Paneni, 2013, Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I, Eur. Heart J., 34, 2436, 10.1093/eurheartj/eht149

Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X

Goldberg, 2009, Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications, J. Clin. Endocrinol. Metab., 94, 3171, 10.1210/jc.2008-2534

Kessler, 1998, Von Willebrand factor in diabetic angiopathy, Diabetes Metab., 24, 327

Giannini, 2011, Macrovascular angiopathy in children and adolescents with type 1 diabetes, Diabetes Metab. Res. Rev., 27, 436, 10.1002/dmrr.1195

Yamagishi, 2010, Advanced glycation end products, oxidative stress and diabetic nephropathy, Oxid. Med. Cell. Longev., 3, 101, 10.4161/oxim.3.2.11148

Sena, 2013, Endothelial dysfunction—a major mediator of diabetic vascular disease, Biochim. Biophys. Acta, 1832, 2216, 10.1016/j.bbadis.2013.08.006

Margetic, 2012, Inflammation and haemostasis, Biochem. Med. (Zagreb.), 22, 49, 10.11613/BM.2012.006

Wautier, 1998, Diabetes, advanced glycation endproducts and vascular disease, Vasc. Med., 3, 131, 10.1177/1358836X9800300207

Bakker, 2009, Endothelial dysfunction and diabetes: Roles of hyperglycemia, impaired insulin signaling and obesity, Cell. Tissue Res., 335, 165, 10.1007/s00441-008-0685-6

Libby, 2012, Inflammation in atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 32, 2045, 10.1161/ATVBAHA.108.179705

Badimon, 2012, Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease, Eur. Heart J. Acute Cardiovasc. Care, 1, 60, 10.1177/2048872612441582

Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485

Lecube, A., Pachon, G., Petriz, J., Hernandez, C., and Simo, R. (2011). Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS ONE, 6.

Lee, 2013, Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes, Diabetes, 62, 194, 10.2337/db12-0420

Meng, 2014, Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose, Mol. Neurobiol., 49, 673, 10.1007/s12035-013-8551-2

Koenen, 2011, Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue, Diabetes, 60, 517, 10.2337/db10-0266

Zeadin, 2013, Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis, Can. J. Diabetes, 37, 345, 10.1016/j.jcjd.2013.06.001

Menegazzo, 2015, NETosis is induced by high glucose and associated with type 2 diabetes, Acta. Diabetol., 52, 497, 10.1007/s00592-014-0676-x

Joshi, 2013, High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation, FEBS Lett., 587, 2241, 10.1016/j.febslet.2013.05.053

Northcott, 2012, Adipokines and the cardiovascular system: Mechanisms mediating health and disease, Can. J. Physiol. Pharmacol., 90, 1029, 10.1139/y2012-053

Yamawaki, 2011, Vascular effects of novel adipocytokines: Focus on vascular contractility and inflammatory responses, Biol. Pharm. Bull., 34, 307, 10.1248/bpb.34.307

Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat. Med., 8, 731, 10.1038/nm724

Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J. Clin. Investig., 117, 2621, 10.1172/JCI31021

Yamauchi, 2003, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects, Nature, 423, 762, 10.1038/nature01705

Fang, 2018, Adiponectin Regulation and Function, Compr. Physiol., 8, 1031, 10.1002/cphy.c170046

Ye, 2015, Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets, Endocrinology, 156, 2019, 10.1210/en.2015-1066

Mandal, 2011, Molecular mechanism for adiponectin-dependent M2 macrophage polarization: Link between the metabolic and innate immune activity of full-length adiponectin, J. Biol. Chem., 286, 13460, 10.1074/jbc.M110.204644

Caligiuri, 2008, Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells, Hepatology, 47, 668, 10.1002/hep.21995

Ezenwaka, 2005, Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects, Neth. J. Med., 63, 64

Dullaart, 2010, Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome, Atherosclerosis, 211, 393, 10.1016/j.atherosclerosis.2010.03.024

Iwashima, 2004, Hypoadiponectinemia is an independent risk factor for hypertension, Hypertension, 43, 1318, 10.1161/01.HYP.0000129281.03801.4b

Pilz, 2005, Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin, J. Clin. Endocrinol. Metab., 90, 4792, 10.1210/jc.2005-0167

Sattar, 2006, Adiponectin and coronary heart disease: A prospective study and meta-analysis, Circulation, 114, 623, 10.1161/CIRCULATIONAHA.106.618918

Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057

Yang, 2006, Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action, Am. J. Physiol. Endocrinol. Metab., 290, E1253, 10.1152/ajpendo.00572.2004

Landecho, M.F., Tuero, C., Valenti, V., Bilbao, I., de la Higuera, M., and Fruhbeck, G. (2019). Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Nutrients, 11.

Schaffler, 2005, Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue, Biochim. Biophys. Acta, 1732, 96, 10.1016/j.bbaexp.2005.11.005

Auguet, T., Quintero, Y., Riesco, D., Morancho, B., Terra, X., Crescenti, A., Broch, M., Aguilar, C., Olona, M., and Porras, J.A. (2011). New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet., 12.

Pan, 2010, Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes, Diabetes Res. Clin. Pract., 88, 29, 10.1016/j.diabres.2010.01.013

Tan, 2008, Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: Ex vivo and in vivo regulation of omentin-1 by insulin and glucose, Diabetes, 57, 801, 10.2337/db07-0990

Cai, 2009, Expression of omentin in adipose tissues in obese and type 2 diabetic patients, Zhonghua Yi Xue Za Zhi, 89, 381

Elsaid, 2018, Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters, J. Clin. Transl. Endocrinol., 13, 14

Wang, 2020, Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4/MyD88/NF-kappaB signaling, Arch. Biochem. Biophys., 679, 108187, 10.1016/j.abb.2019.108187

Agra, 2017, Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells, Obesity (Silver Spring), 25, 1042, 10.1002/oby.21832

Mirzaei, 2016, Modulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake, J. Am. Coll. Nutr., 35, 670, 10.1080/07315724.2015.1126207

Dimova, 2015, The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis, Biomed. Res. Int., 2015, 823481, 10.1155/2015/823481

Esteghamati, 2014, Association of vaspin with metabolic syndrome: The pivotal role of insulin resistance, Diabetes Metab. J., 38, 143, 10.4093/dmj.2014.38.2.143

Choi, 2011, Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women, Clin. Endocrinol. (Oxf.), 75, 628, 10.1111/j.1365-2265.2011.04095.x